ArticleActa crystallographica. Section C, Structural chemistry2026
On the SHELX, PLATON and IUCr/checkCIF crystal structure validation platform.
Article in Acta crystallographica. Section C, Structural chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With checkCIF the IUCr has created a unique platform for the validation and archiving of the result of a small-molecule crystal structure study. That information, supplied in CIF (crystallographic information file) format, should include not only the numerical results of that study but also much of the supporting experimental data and details of the procedures used during the structural investigation. This not only allows for a proper validation of a structure report but also provides an option for a future re-evaluation or use of the data for an unrelated study. The experimental data might be difficult to obtain again or even unique. George Sheldrick's SHELX software was an early adopter of CIF and with that has played a major role in the success of the IUCr validation effort. IUCr/checkCIF initially started out with tests that check for the completeness of the supplied data, along with tests that check whether their values are within the expected range. Currently, the PLATON software carries out most of the tests in the IUCr/checkCIF software framework. Validation issues are reported as a set of ALERTS along with a short clarification. All ALERT messages should be inspected, addressed with a correction where applicable or a short explanation of a special situation. Some ALERT messages are informative but do not necessarily need a comment. More detailed information about a reported issue, such as warnings about missed twinning, missed additional symmetry or voids, might be obtained with a locally installed version of the PLATON software using the same tools on which those ALERTS are based. As an example of this, the use of the PLATON/TwinRotMat tool for the detection of twinning is discussed along with some details about the underlying algorithm. Three twinning examples are presented, covering merohedral, pseudomerohedral and non-merohedral twins, to illustrate the additional twinning information that can be obtained beyond what is shown as an ALERT in the IUCr/checkCIF report.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.